Navigation Links
Breaking Study: ICU Medical's Tego® Needlefree Connector Proves More Cost Effective Than Traditional Central Venous Catheter Locks
Date:12/13/2011

SAN CLEMENTE, Calif., Dec. 13, 2011 /PRNewswire/ --  ICU Medical, Inc. (NASDAQ: ICUI) announced that a clinical study presented at the American Society of Nephrology's (ASN) Kidney Week 2011 showed the Tego® needlefree hemodialysis connector can decrease heparin use and reduce costs for dialysis clinics. As the world's first and only needlefree connector FDA-cleared for use in hemodialysis applications, the Tego connector provides a cost effective alternative to traditional connectors without affecting blood flow rate or the rate of positive blood cultures.

For the study titled Tego® Connectors Reduce Heparin Use without Affecting Blood Flow Rate Compared to Traditional Central Venous Catheter Locks, researchers from DaVita Clinical Researchä (DCR), a provider of clinical research services focused on kidney research as well as a multitude of specialty therapeutic populations, analyzed clinical data from more than 2,500 patients, comparing conversion from traditional central venous catheter (CVC) locks to Tego connectors. Researchers examined data gathered 90 days before and 90 days immediately following the Tego conversion, evaluating blood flow rate, heparin use, and blood culture results. From this data, a cost analysis was conducted, comparing the cost of heparin, connectors, syringes, activase, sodium citrate, and equipment for both CVC locks and Tego connectors to the cost of recombinant tissue plasminogen activator (rt-PA).

Researchers showed that total heparin use decreased by nearly 2000 units three months after the Tego conversion, reducing costs by an average of $16.38 per CVC compared to traditional CVC locks, and "significantly" reducing costs when compared to rt-PA. This study provides evidence to support the Tego's ability to reduce costs associated with long-term CVC without the use of heparin CVC locks. The researchers concluded that since blood flow rate and the rate of positive blood cultures were essentially unchanged after conversion that "Tego connectors are a viable and cost-effective alternative to traditional locks."

Media Contact: Tom McCall 
Vice President, Marketing
949-366-4368
tmccall@icumed.com

About ICU Medical, Inc.: ICU Medical, Inc. develops, manufactures and sells innovative medical devices used in vascular therapy, oncology and critical care applications. ICU Medical's products improve patient outcomes by helping prevent bloodstream infections and protecting healthcare workers from exposure to infectious diseases or hazardous drugs. The company's complete product line includes custom I.V. systems, closed delivery systems for hazardous drugs, needlefree I.V. connectors, catheters and cardiac monitoring systems. ICU Medical is headquartered in San Clemente, California.

 


'/>"/>
SOURCE ICU Medical, Inc.
Copyright©2010 PR Newswire.
All rights reserved

Related biology technology :

1. 15-Minute Data From Phase 3 Study of Avanafil Featured as a Late Breaking Abstract at SMSNA Annual Meeting
2. Chimerix Announces Late-Breaking Poster Presentation at Kidney Week 2011 Annual Meeting
3. Data From REMEDEE Trial Featuring OrbusNeichs Combo™ Dual Therapy Stent to be Presented in Late Breaking Clinical Trials and First Report Investigations Session at TCT 2011
4. Campaign for Cancer Prevention Connects 6 Million+ Members on Facebook Causes to Groundbreaking Research at Brigham and Womens Hospital
5. Breaking Kashas rule
6. ERA-EDTA Congress 2011: Late Breaking Clinical Trials I
7. Breaking the ice before it begins
8. Medicago holds official groundbreaking ceremony for its U.S. commercial grade vaccine facility
9. BellBrook Labs Launches Groundbreaking New Microplate for High Content Chemotaxis Assays in a Stable Gradient
10. Groundbreaking International Training Lab to Strengthen Food Safety in U.S. and Globally
11. Texas-Based Consortium Announces Project GreenVax: A Groundbreaking Vaccine Manufacturing Research Program
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/23/2017)... ... , ... Cambridge Semantics , the leading provider of Big Data management ... and Expo in Boston May 23-25 with a featured speaker and solution demos ... Lake is also a finalist for the Best of Show award. , James LaPointe, ...
(Date:5/22/2017)... ... May 22, 2017 , ... Cancer diagnostics and pathology workflow ... at the Association for Pathology Informatics Annual Summit at the Wyndham ... its Cancer Diagnostic Cockpit and Consultation Portal, Inspirata will present research it led ...
(Date:5/19/2017)... ... 19, 2017 , ... The University City Science Center is ... for commercialization, and who are affiliated with the 21 partner academic and research ... now in its tenth round, is the first multi-institutional proof-of-concept program for the ...
(Date:5/18/2017)... ... May 17, 2017 , ... NDA Partners Chairman Carl Peck, MD ... Eurofins Advantar Laboratories and President of Pharmaceutical Development Business Unit of Cardinal Health, has ... and Cardinal Health, he was former Chief Operating Officer at Anaborex, Senior VP and ...
Breaking Biology Technology:
(Date:3/30/2017)... -- The research team of The Hong Kong Polytechnic ... by adopting ground breaking 3D fingerprint minutiae recovery and matching technology, ... accuracy for use in identification, crime investigation, immigration control, security of ... ... A research team led by Dr ...
(Date:3/27/2017)... March 27, 2017  Catholic Health Services (CHS) ... Systems Society (HIMSS) Analytics for achieving Stage 6 ... sm . In addition, CHS previously earned a ... using an electronic medical record (EMR). ... level of EMR usage in an outpatient setting.  ...
(Date:3/23/2017)... DUBLIN , Mar. 23, 2017 Research ... Anti-Theft System Market Analysis & Trends - Industry Forecast to 2025" ... ... to grow at a CAGR of around 8.8% over the next ... This industry report analyzes the market estimates and forecasts for all ...
Breaking Biology News(10 mins):